Aclaris Therapeutics
ACRS • NASDAQ • Stock Fundamentals
Aclaris Therapeutics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Neal S. Walker, with a market cap of $610.3M.
Market Cap$610.3M
Employees91.0
CEONeal S. Walker
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Aclaris Therapeutics FAQ
Common questions about Aclaris Therapeutics
Aclaris Therapeutics (ACRS) has a market capitalization of $610.3M and trades on NASDAQ.
Aclaris Therapeutics has approximately 91 employees.